{
  "meta": {
    "title": "Ild_Pleural_Disorders",
    "url": "https://brainandscalpel.vercel.app/ild-pleural-disorders-40d264db.html",
    "scrapedAt": "2025-11-29T18:25:12.821Z"
  },
  "questions": [
    {
      "id": 20283,
      "choices": [
        {
          "id": 81093,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transudative</span></span></p>"
        },
        {
          "id": 81094,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exudative</span></span></p>"
        },
        {
          "id": 81095,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignant</span></span></p>"
        },
        {
          "id": 81096,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemorrhagic</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presents with dyspnea and pleuritic chest pain. A chest X-ray reveals a pleural effusion. Diagnostic thoracentesis is performed, and pleural fluid analysis shows the following: pleural fluid protein/serum protein ratio of 0.7. How would this pleural effusion be classified?</span></span></p>",
      "unique_key": "Q6826751",
      "question_audio": null,
      "question_video": null,
      "map_id": 20231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Exudative</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to Light&#39;s criteria, a pleural effusion is classified as exudative if one or more of the following criteria are met:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pleural fluid protein/serum protein ratio &gt; 0.5</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pleural fluid LDH/serum LDH ratio &gt; 0.6</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pleural fluid LDH is greater than two-thirds of the upper limit of normal for serum LDH.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, the pleural fluid protein/serum protein ratio is 0.7, the pleural fluid LDH/serum LDH ratio is 0.8, and the pleural fluid LDH is greater than two-thirds of the upper limit of normal for serum LDH, fulfilling all criteria for an exudative effusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Transudative</span></strong><span style=\"font-size:12.0pt\">: Transudative effusions do not meet Light&#39;s criteria for exudative effusions and are typically due to systemic factors such as heart failure or cirrhosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Malignant</span></strong><span style=\"font-size:12.0pt\">: While malignancy can cause exudative effusions, this classification is based on Light&#39;s criteria, not etiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hemorrhagic</span></strong><span style=\"font-size:12.0pt\">: Refers to the presence of blood in the pleural fluid, which is a descriptive term rather than a classification based on Light&#39;s criteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A pleural effusion is classified as exudative if one or more of Light&#39;s criteria are met, such as a pleural fluid protein/serum protein ratio &gt; 0.5. In this case, the pleural fluid protein/serum protein ratio is 0.7, classifying it as exudative.</span></span></span></p>",
      "correct_choice_id": 81094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49956,
      "choices": [
        {
          "id": 199383,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loculated pleural fluid</span></span></span></p>"
        },
        {
          "id": 199384,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pleural fluid pH &lt; 7.2</span></span></span></p>"
        },
        {
          "id": 199385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pleural fluid glucose &lt; 60 mg/dL</span></span></span></p>"
        },
        {
          "id": 199386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of gross pus in the pleural space</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presents with dyspnea and pleuritic chest pain. Thoracentesis reveals loculated pleural fluid, pH of 7.15, glucose of 2.8 mmol/L (50 mg/dL), and gross pus in the pleural space. Which of the following is not an indication for chest drain placement?</span></span></p>",
      "unique_key": "Q1105899",
      "question_audio": null,
      "question_video": null,
      "map_id": 24910,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Pleural fluid glucose &lt;60 mg/dL)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While low pleural fluid glucose (&lt;3.3 mmol/L or &lt;60 mg/dL) suggests a complicated effusion, it is not an absolute indication for chest drain placement. The other conditions&mdash;loculated fluid, low pH (&lt;7.20), and gross pus&mdash;definitely indicate the need for drainage to prevent or treat empyema or complicated parapneumonic effusions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Loculated pleural fluid</span></strong><span style=\"font-size:12.0pt\">: Indicates complicated effusion that often requires drainage</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pleural fluid pH &lt;7.2</span></strong><span style=\"font-size:12.0pt\">: Suggests a more severe infection or inflammation needing drainage</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Presence of gross pus in the pleural space:</span></strong><span style=\"font-size:12.0pt\"> Clearly indicates empyema, which requires drainage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While low pleural fluid glucose (&lt;3.3 mmol/L or &lt;60 mg/dL) suggests a complicated effusion, it is not an absolute indication for chest drain placement. However, loculated pleural fluid, pleural fluid pH &lt;7.2, and the presence of gross pus in the pleural space are definite indications for chest drain placement to prevent or treat empyema or complicated parapneumonic effusions.</span></span></span></p>",
      "correct_choice_id": 199385,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49957,
      "choices": [
        {
          "id": 199387,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intrapleural fibrinolytic agents alone</span></span></p>"
        },
        {
          "id": 199388,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)</span></span></span></p>"
        },
        {
          "id": 199389,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeat thoracostomy</span></span></p>"
        },
        {
          "id": 199390,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-dose corticosteroids</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old patient with loculated pleural effusion has been treated with antibiotics and tube thoracostomy. Despite treatment, the patient continues to have fever, leukocytosis, and anorexia. Which of the following treatments should be considered next to improve clinical outcomes ?</span></span></span></p>",
      "unique_key": "Q8254107",
      "question_audio": null,
      "question_video": null,
      "map_id": 24911,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) has been shown in controlled trials to improve clinical outcomes, including increased drainage, decreased length of stay, and decreased surgical referral, compared with placebo or either agent alone. This treatment should be considered when fever, leukocytosis, or anorexia persist despite antibiotics and tube thoracostomy, or when the lung fails to re-expand.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intrapleural fibrinolytic agents alone</span></strong><span style=\"font-size:12.0pt\">: Controlled trials have not shown improvement in drainage with fibrinolytic agents alone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Repeat thoracostomy</span></strong><span style=\"font-size:12.0pt\">: Not typically the next step when combination therapy of tPA and DNase can be more effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. High-dose corticosteroids</span></strong><span style=\"font-size:12.0pt\">: Not indicated for improving drainage or treating persistent symptoms in pleural effusion</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) should be considered when fever, leukocytosis, or anorexia persist despite antibiotics and tube thoracostomy, as this combination has been shown to improve clinical outcomes, including increased drainage, decreased length of stay, and decreased surgical referral.</span></span></span></p>",
      "correct_choice_id": 199388,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49958,
      "choices": [
        {
          "id": 199391,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uncomplicated parapneumonic effusion </span></span></span></p>"
        },
        {
          "id": 199392,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignancy </span></span></span></p>"
        },
        {
          "id": 199393,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Esophageal rupture </span></span></span></p>"
        },
        {
          "id": 199394,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male with a history of alcoholism presents with acute onset of left-sided chest pain and shortness of breath. Chest X-ray reveals a left-sided pleural effusion and pneumothorax. Thoracentesis yields turbid, red-brown fluid with a pH of 5.5. Which of the following is the most likely diagnosis ? </span></span></p>",
      "unique_key": "Q9677121",
      "question_audio": null,
      "question_video": null,
      "map_id": 24912,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Esophageal rupture</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of pleural effusion, pneumothorax, red-brown fluid, and low pH is strongly suggestive of esophageal rupture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Uncomplicated parapneumonic effusions</span></strong><span style=\"font-size:12.0pt\"> typically have clear to turbid fluid with a near normal pH</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Malignant</span></strong><span style=\"font-size:12.0pt\"> effusions are rarely associated with pneumothorax or a low pH</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tuberculosis</span></strong><span style=\"font-size:12.0pt\"> effusions are usually serous to serosanguineous &nbsp;and have a near normal pH</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of pleural effusion, pneumothorax, red-brown fluid, and low pH strongly suggests esophageal rupture.</span></span></span></p>",
      "correct_choice_id": 199393,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49959,
      "choices": [
        {
          "id": 199395,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary infarction </span></span></p>"
        },
        {
          "id": 199396,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal rupture </span></span></p>"
        },
        {
          "id": 199397,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy </span></span></p>"
        },
        {
          "id": 199398,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parapneumonic effusion</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 70-year-old male presents with sudden onset of pleuritic chest pain and dyspnea. On examination he had an irregularly irregular pulse. X ray showed a wedge shaped opacity with effusion in the left lung. Which of the following is the most likely cause of the effusion ? </span></span></span></p>",
      "unique_key": "Q7581700",
      "question_audio": null,
      "question_video": null,
      "map_id": 24913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Pulmonary infarction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of sudden-onset pleuritic chest pain, dyspnea, irregularly irregular pulse (suggesting atrial fibrillation), and a wedge-shaped opacity on chest X-ray is highly suggestive of pulmonary embolism with subsequent pulmonary infarction. The infarction causes localized tissue damage and inflammation, leading to the pleural effusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Esophageal rupture:</span></strong><span style=\"font-size:12.0pt\"> This would present with severe chest pain, often radiating to the back, and may be associated with subcutaneous emphysema or mediastinal air.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Malignancy:</span></strong><span style=\"font-size:12.0pt\"> While malignancy can cause pleural effusions, they are typically more indolent in onset and not associated with the acute presentation or wedge-shaped opacity seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Parapneumonic effusion:</span></strong><span style=\"font-size:12.0pt\"> This is an effusion associated with pneumonia and would likely present with fever, cough, and a more diffuse consolidation on chest X-ray.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of sudden-onset pleuritic chest pain, dyspnea, irregularly irregular pulse (suggesting atrial fibrillation), and a wedge-shaped opacity on chest X-ray is highly suggestive of pulmonary embolism with subsequent pulmonary infarction, which can cause pleural effusion.</span></span></span></p>",
      "correct_choice_id": 199395,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49960,
      "choices": [
        {
          "id": 199399,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Empyema </span></span></p>"
        },
        {
          "id": 199400,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylothorax </span></span></p>"
        },
        {
          "id": 199401,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemothorax </span></span></p>"
        },
        {
          "id": 199402,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudochylous effusion</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male with a history of lymphoma presents with dyspnea and a large pleural effusion. Pleural fluid analysis reveals a milky white appearance and an elevated triglyceride level. Which of the following is the most likely diagnosis ? </span></span></p>",
      "unique_key": "Q2477492",
      "question_audio": null,
      "question_video": null,
      "map_id": 24914,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Chylothorax</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The milky white appearance and elevated triglyceride level are characteristic of chylothorax, which is caused by a disruption of the thoracic duct.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Empyema</span></strong><span style=\"font-size:12.0pt\"> presents with purulent fluid and a low glucose level. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hemothorax</span></strong><span style=\"font-size:12.0pt\"> presents with bloody fluid. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pseudochylothorax</span></strong><span style=\"font-size:12.0pt\"> has a milky white appearance but normal triglyceride levels</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A milky white appearance and elevated triglyceride level in pleural fluid are characteristic of chylothorax, which results from the disruption of the thoracic duct.</span></span></span></p>",
      "correct_choice_id": 199400,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49961,
      "choices": [
        {
          "id": 199403,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 mm </span></span></p>"
        },
        {
          "id": 199404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">10 mm </span></span></span></p>"
        },
        {
          "id": 199405,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">15 mm </span></span></p>"
        },
        {
          "id": 199406,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20 mm</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 55-year-old male presents with a gradual onset of dyspnea and a non-productive cough. Ultrasound confirms the presence of pleural effusion. Which of the following minimum fluid pocket depths on ultrasound would be considered adequate for a safe diagnostic thoracentesis?</span></span></span></p>",
      "unique_key": "Q4171499",
      "question_audio": null,
      "question_video": null,
      "map_id": 24915,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 10 mm</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A minimum pleural fluid pocket depth of 10 mm on ultrasound is generally considered adequate for a safe diagnostic thoracentesis. This depth allows for sufficient space to insert the needle and aspirate fluid without risking lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 5 mm:</span></strong><span style=\"font-size:12.0pt\"> This is too shallow and increases the risk of puncturing the lung.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 15 mm and D. 20 mm:</span></strong><span style=\"font-size:12.0pt\"> While these depths are safe, they are not the minimum required. A 10 mm pocket is sufficient for a diagnostic thoracentesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A minimum pleural fluid pocket depth of 10 mm on ultrasound is considered adequate for a safe diagnostic thoracentesis, providing sufficient space to insert the needle and aspirate fluid without risking lung injury.</span></span></span></p>",
      "correct_choice_id": 199404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49962,
      "choices": [
        {
          "id": 199407,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is most likely a secondary spontaneous pneumothorax due to underlying lung disease</span></span></p>"
        },
        {
          "id": 199408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of apical blebs is highly suggestive of Marfan syndrome</span></span></span></p>"
        },
        {
          "id": 199409,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Smoking is an important risk factor</span></span></p>"
        },
        {
          "id": 199410,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrence of pneumothorax is unlikely in this patient population.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 24-year-old tall, thin male presents with acute-onset left-sided chest pain and shortness of breath. He reports a 10-pack-year smoking history. Chest X-ray reveals a small apical pneumothorax. Which of the following statements is most accurate regarding his condition?</span></span></span></p>",
      "unique_key": "Q4683637",
      "question_audio": null,
      "question_video": null,
      "map_id": 24916,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) smoking is an important risk factor</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp; </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>This is most likely a secondary spontaneous pneumothorax due to underlying lung disease</strong>:&nbsp;This is likely a primary, not secondary, spontaneous pneumothorax given the absence of underlying lung disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>The presence of apical blebs is highly suggestive of Marfan syndrome</strong>:&nbsp;Apical blebs are not specific to Marfan syndrome; they are common in Primary spontaneous pneumothorax</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Recurrence of pneumothorax is unlikely in this patient population</span></strong><span style=\"font-size:12.0pt\">:&nbsp;Recurrence of PSP is common, especially in smokers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Smoking is an important risk factor for primary spontaneous pneumothorax, which is often associated with the rupture of subpleural apical blebs in young, tall, thin individuals. Recurrence is common, especially in smokers.</span></span></span></p>",
      "correct_choice_id": 199409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49963,
      "choices": [
        {
          "id": 199411,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pneumonia </span></span></p>"
        },
        {
          "id": 199412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism </span></span></span></p>"
        },
        {
          "id": 199413,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary spontaneous pneumothorax </span></span></p>"
        },
        {
          "id": 199414,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tension pneumothorax</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old male with no significant past medical history presents to the emergency department with sudden onset of sharp, right-sided chest pain and shortness of breath. His JVP is normal and BP is 110/70 mm Hg. He denies any recent trauma or illness. X-ray is shown. What is the likely diagnosis ?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-160110.png\" style=\"height:332px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3439190",
      "question_audio": null,
      "question_video": null,
      "map_id": 24917,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Primary spontaneous pneumothorax</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The chest X-ray demonstrates a visible visceral pleural line with no lung markings peripheral to it, which is diagnostic of a pneumothorax. Given the patient&#39;s young age, lack of underlying lung disease, and absence of trauma, the most likely diagnosis is a primary spontaneous pneumothorax. Primary spontaneous pneumothorax typically occurs due to the rupture of apical blebs in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pneumonia:</span></strong><span style=\"font-size:12.0pt\"> would typically present with consolidation or infiltrates on chest x-ray.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pulmonary embolism:</span></strong><span style=\"font-size:12.0pt\"> could present with chest pain and shortness of breath, but x-ray findings are usually normal or show subtle abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tension pneumothorax:</span></strong><span style=\"font-size:12.0pt\"> this is a life-threatening emergency where the patients would be having high JVP and hypotension and X rays usually show mediastinal shift and tracheal deviation, which are not seen in this image. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The chest X-ray shows a visible visceral pleural line with no lung markings peripheral to it, indicating a pneumothorax. Given the patient&#39;s young age, lack of underlying lung disease, and absence of trauma, the most likely diagnosis is a primary spontaneous pneumothorax, typically caused by the rupture of apical blebs in the lungs.</span></span></span></p>",
      "correct_choice_id": 199413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49964,
      "choices": [
        {
          "id": 199415,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest X-ray to confirm the diagnosis </span></span></p>"
        },
        {
          "id": 199416,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Needle decompression in the second intercostal space, midclavicular line </span></span></p>"
        },
        {
          "id": 199417,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placement of a chest tube in the fourth intercostal space, anterior axillary line </span></span></p>"
        },
        {
          "id": 199418,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intubation and mechanical ventilation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old male presents to the emergency department with sudden onset of shortness of breath, chest pain, and tachycardia. Upon examination, he has decreased breath sounds on the left side, jugular venous distention, and tracheal deviation to the right. The most appropriate immediate management of this patient is:</span></span></p>",
      "unique_key": "Q3121723",
      "question_audio": null,
      "question_video": null,
      "map_id": 24918,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Needle decompression in the second intercostal space, midclavicular line</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation and physical exam findings are highly suggestive of a tension pneumothorax, a life-threatening condition. The immediate management of a tension pneumothorax is needle decompression to relieve the pressure in the pleural space. This is performed by inserting a large-bore needle in the second intercostal space, midclavicular line on the affected side.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(Note that <em><u>ATLS 10<sup>th</sup> edition recommends needle thoracostomy to be done in the 5<sup>th</sup> ICS in the mid-axillary line</u></em>. But this is often difficult in obese individuals and has a higher failure rate as the chest wall is thicker at the 5<sup>th</sup> ICS. Also, it is difficult in pre-hospital settings as arm movements in the ambulance or by the patient can disrupt the catheters in place)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chest X-ray to confirm the diagnosis:</span></strong><span style=\"font-size:12.0pt\"> While a chest X-ray can confirm the diagnosis, it should not delay the immediate treatment of needle decompression in a suspected tension pneumothorax.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Placement of a chest tube in the fourth intercostal space, anterior axillary line:</span></strong><span style=\"font-size:12.0pt\"> This is the definitive treatment for pneumothorax, but needle decompression is the immediate life-saving intervention in a tension pneumothorax.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Intubation and mechanical ventilation:</span></strong><span style=\"font-size:12.0pt\"> While intubation and mechanical ventilation may be necessary later in the management, needle decompression is the priority in stabilizing the patient&#39;s condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The immediate management of a tension pneumothorax is needle decompression in the second intercostal space, midclavicular line, to relieve the pressure in the pleural space and stabilize the patient&#39;s condition. This is a life-saving intervention that should be performed promptly based on clinical suspicion without waiting for imaging confirmation.</span></span></span></p>",
      "correct_choice_id": 199416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20198,
      "choices": [
        {
          "id": 80754,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CFTR</span></span></p>"
        },
        {
          "id": 80755,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUC5B</span></span></p>"
        },
        {
          "id": 80756,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1</span></span></p>"
        },
        {
          "id": 80757,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KRAS</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 70-year-old man is diagnosed with idiopathic pulmonary fibrosis (IPF) after presenting with progressive dyspnea and a dry cough and he has a strong family history. Which gene mutation is most commonly associated with idiopathic pulmonary fibrosis?</span></span></span></p>",
      "unique_key": "Q5183321",
      "question_audio": null,
      "question_video": null,
      "map_id": 20146,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;Ans. B)&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">MUC5B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The MUC5B gene mutation is the most commonly associated genetic variant with idiopathic pulmonary fibrosis (IPF). This mutation is linked to the production of mucin, a component of mucus, and has been shown to influence the prognosis and progression of the disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. CFTR:</span></strong><span style=\"font-size:12.0pt\"> Associated with cystic fibrosis, not IPF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. BRCA1:</span></strong><span style=\"font-size:12.0pt\"> Associated with breast and ovarian cancer, not IPF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. KRAS:</span></strong><span style=\"font-size:12.0pt\"> Commonly associated with various cancers, including lung cancer, but not specifically IPF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Educational Objective</u>:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The MUC5B gene mutation is the most commonly associated genetic variant with idiopathic pulmonary fibrosis (IPF).</span></span></span></p>",
      "correct_choice_id": 80755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20202,
      "choices": [
        {
          "id": 80769,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-specific interstitial pneumonia</span></span></p>"
        },
        {
          "id": 80770,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Desquamative interstitial pneumonia</span></span></p>"
        },
        {
          "id": 80771,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic pulmonary fibrosis</span></span></p>"
        },
        {
          "id": 80772,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory bronchiolitis associated interstitial lung disease</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 68-year-old woman presents with progressive shortness of breath and a dry cough. High-resolution CT of the chest reveals honeycombing and reticular opacities. Based on epidemiological data, which of the following is the most common interstitial lung disease?</span></span></span></p>",
      "unique_key": "Q2341871",
      "question_audio": null,
      "question_video": null,
      "map_id": 20149,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;Ans. C)&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Idiopathic pulmonary fibrosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease, characterized by progressive scarring of the lung tissue leading to respiratory failure. It is often diagnosed in older adults and has a poor prognosis. The presence of honeycombing and reticular opacities on high-resolution CT is indicative of IPF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Non-specific interstitial pneumonia:</span></strong><span style=\"font-size:12.0pt\"> Less common than IPF and has different radiographic and clinical features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Desquamative interstitial pneumonia:</span></strong><span style=\"font-size:12.0pt\"> Also less common and typically associated with smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Respiratory bronchiolitis associated interstitial lung disease:</span></strong><span style=\"font-size:12.0pt\"> Primarily seen in smokers but less common than IPF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong> </span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The most common interstitial lung disease is idiopathic pulmonary fibrosis.</span></strong></span></span></p>",
      "correct_choice_id": 80771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20216,
      "choices": [
        {
          "id": 80825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic obstructive pulmonary disease (COPD)</span></span></span></p>"
        },
        {
          "id": 80826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interstitial lung disease (ILD)</span></span></span></p>"
        },
        {
          "id": 80827,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic bronchitis</span></span></p>"
        },
        {
          "id": 80828,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung cancer</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old retired coal miner presents with progressive shortness of breath and chronic cough. He has a long history of working in coal mines. Which of the following conditions is least likely to be associated with his occupational history?</span></span></span></p>",
      "unique_key": "Q7588020",
      "question_audio": null,
      "question_video": null,
      "map_id": 20164,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Lung cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coal workers&#39; pneumoconiosis (CWP), also known as black lung disease, is associated with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and chronic bronchitis due to long-term inhalation of coal dust. These conditions lead to progressive lung damage and respiratory impairment. However, CWP is not directly associated with an increased risk of lung cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chronic obstructive pulmonary disease (COPD):</span></strong><span style=\"font-size:12.0pt\"> CWP can lead to the development of COPD due to long-term exposure to coal dust.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Interstitial lung disease (ILD):</span></strong><span style=\"font-size:12.0pt\"> CWP is a form of ILD caused by coal dust inhalation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic bronchitis: </span></strong><span style=\"font-size:12.0pt\">Chronic bronchitis is common in coal workers due to continuous exposure to coal dust.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coal workers&#39; pneumoconiosis (CWP), or black lung disease, is associated with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and chronic bronchitis due to long-term inhalation of coal dust. However, CWP is not directly associated with an increased risk of lung cancer.</span></span></span></p>",
      "correct_choice_id": 80828,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20217,
      "choices": [
        {
          "id": 80829,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis</span></span></p>"
        },
        {
          "id": 80830,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis</span></span></p>"
        },
        {
          "id": 80831,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caplan syndrome</span></span></p>"
        },
        {
          "id": 80832,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial lung disease</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of working in the mining industry presents with chronic cough and joint pain. Chest X-ray shows multiple, rounded nodules in the lungs. He also has a known diagnosis of rheumatoid arthritis. Which of the following diagnoses best explains his clinical presentation?</span></span></p>",
      "unique_key": "Q8417243",
      "question_audio": null,
      "question_video": null,
      "map_id": 20165,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Caplan syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caplan syndrome, also known as rheumatoid pneumoconiosis, occurs in patients with rheumatoid arthritis who are exposed to dust such as silica or coal dust. It is characterized by the presence of multiple, rounded nodules on chest X-ray in the setting of underlying pneumoconiosis and rheumatoid arthritis. This condition combines features of both rheumatoid arthritis and pneumoconiosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sarcoidosis:</span></strong><span style=\"font-size:12.0pt\"> Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not typically associated with rheumatoid arthritis and mining exposure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tuberculosis:</span></strong><span style=\"font-size:12.0pt\"> Typically presents with cavitary lesions or consolidations, not rounded nodules, and is not associated with rheumatoid arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Interstitial lung disease (ILD):</span></strong><span style=\"font-size:12.0pt\"> Refers to a group of disorders causing fibrosis and scarring of the lung tissue, which can include conditions like idiopathic pulmonary fibrosis, but does not typically present with the specific combination of rheumatoid arthritis and mining exposure seen in Caplan syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caplan syndrome, or rheumatoid pneumoconiosis, occurs in patients with rheumatoid arthritis who are exposed to dust such as silica or coal dust. It is characterized by multiple, rounded nodules on chest X-ray in the setting of pneumoconiosis and rheumatoid arthritis.</span></span></span></p>",
      "correct_choice_id": 80831,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20223,
      "choices": [
        {
          "id": 80853,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchoalveolar lavage (BAL) with CD4/CD8 ratio</span></span></p>"
        },
        {
          "id": 80854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Beryllium lymphocyte proliferation test (BeLPT)</span></span></span></p>"
        },
        {
          "id": 80855,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum angiotensin-converting enzyme (ACE) level</span></span></p>"
        },
        {
          "id": 80856,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HRCT of the chest</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 48-year-old man who works in an aerospace manufacturing plant presents with progressive dyspnea, cough, and fatigue. Chest X-ray showed bilateral hilar lymphadenopathy, and a transbronchial lung biopsy revealed non-caseating granulomas. Which diagnostic test is most appropriate for confirming the diagnosis?</span></span></span></p>",
      "unique_key": "Q5149994",
      "question_audio": null,
      "question_video": null,
      "map_id": 20171,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Beryllium lymphocyte proliferation test (BeLPT)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Beryllium lymphocyte proliferation test (BeLPT) is the most appropriate diagnostic test for confirming chronic beryllium disease (CBD) in a patient with a history of beryllium exposure and findings of non-caseating granulomas on biopsy. The BeLPT measures the proliferation of lymphocytes in response to beryllium exposure and is specific for diagnosing beryllium sensitization and chronic beryllium disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bronchoalveolar lavage (BAL) with CD4/CD8 ratio</span></strong><span style=\"font-size:12.0pt\">: Useful in sarcoidosis but not specific for berylliosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum angiotensin-converting enzyme (ACE) level:</span></strong><span style=\"font-size:12.0pt\"> Elevated in sarcoidosis but not specific for berylliosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. High-resolution CT scan of the chest:</span></strong><span style=\"font-size:12.0pt\"> Helps in identifying interstitial lung disease but does not confirm beryllium exposure or CBD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Beryllium lymphocyte proliferation test (BeLPT) is the most appropriate diagnostic test for confirming chronic beryllium disease (CBD) in a patient with a history of beryllium exposure and findings of non-caseating granulomas on biopsy. The BeLPT measures the proliferation of lymphocytes in response to beryllium exposure and is specific for diagnosing beryllium sensitization and chronic beryllium disease.</span></span></span></p>",
      "correct_choice_id": 80854,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20226,
      "choices": [
        {
          "id": 80865,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchoalveolar lavage (BAL) with lymphocyte count</span></span></p>"
        },
        {
          "id": 80866,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum angiotensin-converting enzyme (ACE) level</span></span></p>"
        },
        {
          "id": 80867,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum antigen-specific IgG testing</span></span></p>"
        },
        {
          "id": 80868,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-caseating granulomas in lung biopsy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with chronic cough, dyspnea, and fatigue. She keeps birds as pets, and high-resolution CT of the chest is done and shown. All are useful for diagnosis except:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-124749.png\" style=\"height:250px; width:300px\" /></span></span></p>",
      "unique_key": "Q5742722",
      "question_audio": null,
      "question_video": null,
      "map_id": 20174,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Serum angiotensin-converting enzyme (ACE) level</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Based on her history of pets, presenting symptoms and CT (showing scattered regions of ground-glass infiltrates in a mosaic pattern (due to&nbsp; air trapping) - Diagnosis is certainly hypersensitivity pneumonitis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum angiotensin-converting enzyme (ACE) level is typically elevated in sarcoidosis but is not specific for hypersensitivity pneumonitis (HP). Therefore, it is not useful for diagnosing HP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bronchoalveolar lavage (BAL) with lymphocyte count</span></strong><span style=\"font-size:12.0pt\">: An increased lymphocyte count and CD4/CD8 ration of &lt; 1 in BAL fluid is indicative of HP and helps in the diagnosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum antigen-specific IgG testing</span></strong><span style=\"font-size:12.0pt\">: Identifies antibodies against specific antigens (such as bird proteins) that can cause HP, making it useful for diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Non-caseating granulomas in lung biopsy</span></strong><span style=\"font-size:12.0pt\">: The presence of non-caseating granulomas is a key histopathological feature of HP, supporting the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum angiotensin-converting enzyme (ACE) level is typically elevated in sarcoidosis but is not specific for hypersensitivity pneumonitis (HP). Therefore, it is not useful for diagnosing HP.</span></span></span></p>",
      "correct_choice_id": 80866,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20228,
      "choices": [
        {
          "id": 80873,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penicillium casei</span></span></p>"
        },
        {
          "id": 80874,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coffee bean dust</span></span></p>"
        },
        {
          "id": 80875,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saccharopolyspora rectivirgula</span></span></p>"
        },
        {
          "id": 80876,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Botrytis cinerea</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old agricultural worker presents with symptoms of chronic cough, dyspnea, and fatigue. He reports working with moldy hay and grain regularly. Based on the table, which pathogen is most likely responsible for his condition?</span></span></p>",
      "unique_key": "Q3473535",
      "question_audio": null,
      "question_video": null,
      "map_id": 20176,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong><strong><span style=\"font-size:12.0pt\">Ans. C) Saccharopolyspora rectivirgula</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The question is based on a table from Harrison&rsquo;s Principles of Internal Medicine (Pg 2160), hence may appear difficult to many.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s occupational exposure to moldy hay and grain is consistent with Farmer&#39;s lung, which is caused by inhaling thermophilic actinomycetes such as Saccharopolyspora rectivirgula. This pathogen is commonly associated with hypersensitivity pneumonitis in individuals who work in farming and food processing environments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Penicillium casei:</span></strong><span style=\"font-size:12.0pt\"> Associated with Cheese washer&rsquo;s lung, not typically found in moldy hay or grain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Coffee bean dust</span></strong><span style=\"font-size:12.0pt\">: Associated with Coffee worker&rsquo;s lung, not relevant to this patient&#39;s agricultural exposure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Botrytis cinerea:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Associated with Wine maker&rsquo;s lung, linked to grape exposure, not moldy hay or grain.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s occupational exposure to moldy hay and grain is consistent with Farmer&#39;s lung, caused by inhaling thermophilic actinomycetes such as Saccharopolyspora rectivirgula.</span></span></span></p>",
      "correct_choice_id": 80875,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20231,
      "choices": [
        {
          "id": 80885,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mikulicz syndrome</span></span></p>"
        },
        {
          "id": 80886,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heerfordt syndrome</span></span></p>"
        },
        {
          "id": 80887,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L&ouml;fgren syndrome</span></span></p>"
        },
        {
          "id": 80888,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blau syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman with a known diagnosis of sarcoidosis presents with new-onset facial weakness and decreased tear production. She also reports episodes of dry mouth and swelling near her jawline. Which specific manifestation of sarcoidosis is most likely?</span></span></p>",
      "unique_key": "Q1412984",
      "question_audio": null,
      "question_video": null,
      "map_id": 20179,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;Ans. B) Heerfordt syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heerfordt syndrome, also known as uveoparotid fever, is a rare manifestation of sarcoidosis characterized by parotid gland enlargement, uveitis, fever, and facial nerve palsy. The patient&rsquo;s symptoms of facial weakness, decreased tear production, dry mouth, and jaw swelling are consistent with this syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Mikulicz syndrome</span></strong><span style=\"font-size:12.0pt\">: Characterized by chronic, painless enlargement of the parotid and lacrimal glands, often associated with Sj&ouml;gren&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. L&ouml;fgren syndrome</span></strong><span style=\"font-size:12.0pt\">: Characterized by bilateral hilar lymphadenopathy, erythema nodosum, and arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Blau syndrome</span></strong><span style=\"font-size:12.0pt\">: A genetic disorder presenting with granulomatous arthritis, uveitis, and dermatitis, seen in children, not related to Heerfordt syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heerfordt syndrome, also known as uveoparotid fever, is a rare manifestation of sarcoidosis characterized by parotid gland enlargement, uveitis, fever, and facial nerve palsy.</span></span></span></p>",
      "correct_choice_id": 80886,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20233,
      "choices": [
        {
          "id": 80893,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L&ouml;fgren syndrome</span></span></p>"
        },
        {
          "id": 80894,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heerfordt syndrome</span></span></p>"
        },
        {
          "id": 80895,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mikulicz syndrome</span></span></p>"
        },
        {
          "id": 80896,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blau syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old African American woman presents with bilateral hilar lymphadenopathy, erythema nodosum, and arthritis. She also reports occasional fever and malaise. What is the most likely clinical syndrome associated with her presentation in the context of sarcoidosis?</span></span></p>",
      "unique_key": "Q8389529",
      "question_audio": null,
      "question_video": null,
      "map_id": 20181,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) L&ouml;fgren syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">L&ouml;fgren syndrome is a clinical syndrome associated with sarcoidosis characterized by the triad of bilateral hilar lymphadenopathy, erythema nodosum, and arthritis, often accompanied by fever and malaise. It is more common in women and has a good prognosis with spontaneous resolution in many cases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Heerfordt syndrome</span></strong><span style=\"font-size:12.0pt\">: Associated with uveoparotid fever, characterized by parotid gland enlargement, uveitis, fever, and facial nerve palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mikulicz syndrome:</span></strong><span style=\"font-size:12.0pt\"> Characterized by chronic, painless enlargement of the parotid and lacrimal glands, not specific to sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Blau syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">A genetic disorder presenting with granulomatous arthritis, uveitis, and dermatitis, seen in children, not related to L&ouml;fgren syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">L&ouml;fgren syndrome is a clinical syndrome associated with sarcoidosis characterized by the triad of bilateral hilar lymphadenopathy, erythema nodosum, and arthritis, often accompanied by fever and malaise.</span></span></span></p>",
      "correct_choice_id": 80893,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20235,
      "choices": [
        {
          "id": 80901,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus vulgaris</span></span></p>"
        },
        {
          "id": 80902,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leprosy</span></span></p>"
        },
        {
          "id": 80903,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus pernio</span></span></p>"
        },
        {
          "id": 80904,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discoid lupus</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents with multiple facial lesions as shown in the image. She also reports chronic fatigue and dyspnea. Biopsy of the skin lesions shows non-caseating granulomas. What is the most likely diagnosis?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-131733.png\" style=\"height:273px; width:300px\" /></span></span></p>",
      "unique_key": "Q4927909",
      "question_audio": null,
      "question_video": null,
      "map_id": 20183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Lupus pernio</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus pernio is a specific form of cutaneous sarcoidosis characterized by chronic, violaceous, indurated lesions on the face, especially around the nose, cheeks, and ears. It is associated with systemic sarcoidosis, which can present with symptoms like chronic fatigue and dyspnea. The presence of non-caseating granulomas on biopsy confirms the diagnosis of sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Lupus vulgaris:</span></strong><span style=\"font-size:12.0pt\"> A form of cutaneous tuberculosis that presents with reddish-brown plaques, not typically associated with non-caseating granulomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Leprosy:</span></strong><span style=\"font-size:12.0pt\"> Presents with hypopigmented or reddish skin lesions with sensory loss and is diagnosed by the presence of Mycobacterium leprae in skin biopsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Discoid lupus</span></strong><span style=\"font-size:12.0pt\">: Presents with chronic discoid lesions, erythematous plaques with scaling, and can be associated with systemic lupus erythematosus, but does not typically show non-caseating granulomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus pernio is a specific form of cutaneous sarcoidosis characterized by chronic, violaceous, indurated lesions on the face, especially around the nose, cheeks, and ears, and is associated with systemic sarcoidosis.</span></span></span></p>",
      "correct_choice_id": 80903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20239,
      "choices": [
        {
          "id": 80917,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Optic neuritis</span></span></p>"
        },
        {
          "id": 80918,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CN VII nerve palsy</span></span></p>"
        },
        {
          "id": 80919,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior hypothalamic involvement</span></span></p>"
        },
        {
          "id": 80920,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Basilar meningitis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old woman with a known diagnosis of sarcoidosis presents with new-onset vision problems and facial droop on one side. Which of the following neurological manifestations is least likely to be associated with her condition?</span></span></span></p>",
      "unique_key": "Q7723633",
      "question_audio": null,
      "question_video": null,
      "map_id": 20192,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Posterior hypothalamic involvement</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp; </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sarcoidosis can involve the nervous system, leading to various neurological manifestations. Common ones include CN VII palsy, Basilar meningitis &nbsp;and anterior hypothalamic involvement (causing Diabetes Insipidus)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CN VII involvement is usually acute and transient (may mimic Bell&rsquo;s Palsy), whereas optic neuritis can be chronic and needs long term treatment. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients can also develop seizures and cognitive dysfunction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Optic neuritis</span></strong><span style=\"font-size:12.0pt\">: Sarcoidosis can cause inflammation of the optic nerve, leading to vision problems.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. 7th nerve palsy</span></strong><span style=\"font-size:12.0pt\">: Facial nerve palsy is a well-known manifestation of neurosarcoidosis, presenting as facial droop.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Basilar meningitis</span></strong><span style=\"font-size:12.0pt\">: Sarcoidosis can lead to chronic basilar meningitis, presenting with symptoms such as headache and cranial nerve deficits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sarcoidosis can involve the nervous system, leading to various neurological manifestations such as CN VII palsy, optic neuritis, and basilar meningitis. Posterior hypothalamic involvement is least likely in this context.</span></span></span></p>",
      "correct_choice_id": 80919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20246,
      "choices": [
        {
          "id": 80945,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate</span></span></p>"
        },
        {
          "id": 80946,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infliximab</span></span></p>"
        },
        {
          "id": 80947,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prednisone</span></span></p>"
        },
        {
          "id": 80948,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Azathioprine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman with biopsy-proven pulmonary sarcoidosis presents with worsening dyspnea and cough. Imaging shows progressive pulmonary involvement which is progressing despite initial management by his clinician. Which of the following is the treatment for refractory disease?</span></span></p>",
      "unique_key": "Q6739578",
      "question_audio": null,
      "question_video": null,
      "map_id": 20194,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Infliximab</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For refractory sarcoidosis, where the disease does not respond adequately to corticosteroids (such as prednisone) or other first-line treatments, infliximab, a TNF-alpha inhibitor, may be considered. Infliximab is used for severe or refractory sarcoidosis, particularly in cases where other treatments have failed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Methotrexate</span></strong><span style=\"font-size:12.0pt\">: Used as a second-line treatment or steroid-sparing agent, but not typically first-line for refractory disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Prednisone</span></strong><span style=\"font-size:12.0pt\">: The first-line treatment for sarcoidosis, but the patient has refractory disease, indicating that prednisone alone is not sufficient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Azathioprine:</span></strong><span style=\"font-size:12.0pt\"> An immunosuppressive agent used as a second-line treatment or steroid-sparing agent, but not the first choice for refractory disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Infliximab, a TNF-alpha inhibitor, is used for treating severe or refractory sarcoidosis when initial treatments such as corticosteroids (e.g., prednisone) and second-line agents (e.g., methotrexate, azathioprine) are not effective.</span></span></span></p>",
      "correct_choice_id": 80946,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20247,
      "choices": [
        {
          "id": 80949,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphangioleiomyomatosis (LAM)</span></span></p>"
        },
        {
          "id": 80950,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis</span></span></p>"
        },
        {
          "id": 80951,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic pulmonary fibrosis (IPF)</span></span></p>"
        },
        {
          "id": 80952,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic obstructive pulmonary disease (COPD)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman presents with progressive dyspnea, recurrent pneumothoraces, and chylous pleural effusions. High-resolution CT of the chest shows diffuse thin-walled cysts. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q1794911",
      "question_audio": null,
      "question_video": null,
      "map_id": 20195,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) Lymphangioleiomyomatosis (LAM)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease that primarily affects women of childbearing age. It is characterized by the abnormal proliferation of smooth muscle-like cells (LAM cells) that can lead to the formation of cysts, recurrent pneumothoraces, and chylous pleural effusions. The presence of diffuse thin-walled cysts on high-resolution CT is a key diagnostic feature of LAM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sarcoidosis:</span></strong><span style=\"font-size:12.0pt\"> Typically presents with bilateral hilar lymphadenopathy and non-caseating granulomas, not diffuse thin-walled cysts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Idiopathic pulmonary fibrosis (IPF):</span></strong><span style=\"font-size:12.0pt\"> Characterized by progressive fibrosis and honeycombing on CT, not thin-walled cysts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chronic obstructive pulmonary disease (COPD):&nbsp;</span></strong><span style=\"font-size:12.0pt\">Characterized by airflow obstruction and emphysematous changes, not diffuse thin-walled cysts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphangioleiomyomatosis (LAM) is a rare lung disease affecting women of childbearing age, characterized by diffuse thin-walled cysts on high-resolution CT, recurrent pneumothoraces, and chylous pleural effusions. It involves the proliferation of abnormal smooth muscle-like cells, distinguishing it from other conditions like sarcoidosis, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease.</span></span></span></p>",
      "correct_choice_id": 80949,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20248,
      "choices": [
        {
          "id": 80953,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic pulmonary fibrosis (IPF)</span></span></p>"
        },
        {
          "id": 80954,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary alveolar proteinosis (PAP)</span></span></p>"
        },
        {
          "id": 80955,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis</span></span></p>"
        },
        {
          "id": 80956,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pneumocystis jirovecii pneumonia (PJP)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old man presents with progressive dyspnea and a chronic cough productive of white, frothy sputum. Chest X-ray shows bilateral alveolar infiltrates, and high-resolution CT of the chest reveals a &quot;crazy paving&quot; pattern. Bronchoalveolar lavage (BAL) yields milky fluid with periodic acid-Schiff (PAS)-positive material. Which of the following is the most likely diagnosis ?</span></span></p>",
      "unique_key": "Q9023735",
      "question_audio": null,
      "question_video": null,
      "map_id": 20196,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong><strong><span style=\"font-size:12.0pt\">Ans. B) Pulmonary alveolar proteinosis (PAP</span></strong><span style=\"font-size:12.0pt\">)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary alveolar proteinosis (PAP) is characterized by the accumulation of surfactant-like material in the alveoli, leading to symptoms such as progressive dyspnea and a chronic cough productive of white, frothy sputum. Radiographic findings include bilateral alveolar infiltrates and a &quot;crazy paving&quot; pattern on high-resolution CT. The presence of PAS-positive material in bronchoalveolar lavage (BAL) fluid is a key diagnostic feature of PAP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Idiopathic pulmonary fibrosis (IPF):</span></strong><span style=\"font-size:12.0pt\"> Typically presents with progressive fibrosis and honeycombing on CT, not a &quot;crazy paving&quot; pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sarcoidosis:</span></strong><span style=\"font-size:12.0pt\"> Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not PAS-positive material in BAL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pneumocystis jirovecii pneumonia (PJP):&nbsp;</span></strong><span style=\"font-size:12.0pt\">Can present with diffuse bilateral infiltrates, but the BAL fluid would typically show Pneumocystis organisms on special staining, not PAS-positive material.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary alveolar proteinosis (PAP) is diagnosed by the accumulation of surfactant-like material in the alveoli, presenting with progressive dyspnea, a chronic cough with white frothy sputum, bilateral alveolar infiltrates on chest X-ray, and a &quot;crazy paving&quot; pattern on high-resolution CT. The presence of PAS-positive material in bronchoalveolar lavage fluid confirms the diagnosis. This condition is distinct from idiopathic pulmonary fibrosis, sarcoidosis, and Pneumocystis jirovecii pneumonia, each having unique diagnostic features and findings.</span></span></span></p>",
      "correct_choice_id": 80954,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20250,
      "choices": [
        {
          "id": 80961,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryptogenic organizing pneumonia (COP)</span></span></p>"
        },
        {
          "id": 80962,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Idiopathic pulmonary fibrosis (IPF)</span></span></span></p>"
        },
        {
          "id": 80963,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis</span></span></p>"
        },
        {
          "id": 80964,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic eosinophilic pneumonia (CEP)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents with a three-month history of non-productive cough, low-grade fever, and progressive dyspnea. Chest X-ray reveals bilateral patchy infiltrates, and high-resolution CT shows peripheral consolidation and ground-glass opacities. Lung biopsy reveals organizing pneumonia with granulation tissue within the alveolar ducts and bronchioles. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q7757250",
      "question_audio": null,
      "question_video": null,
      "map_id": 20198,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) Cryptogenic organizing pneumonia (COP)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cryptogenic organizing pneumonia (COP), previously known as bronchiolitis obliterans organizing pneumonia (BOOP), is characterized by the presence of granulation tissue within the alveolar ducts and bronchioles. It often presents with a subacute onset of symptoms such as non-productive cough, low-grade fever, and progressive dyspnea. Radiographic findings include bilateral patchy infiltrates and peripheral consolidation with ground-glass opacities on high-resolution CT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Idiopathic pulmonary fibrosis (IPF):</span></strong><span style=\"font-size:12.0pt\"> Typically presents with progressive fibrosis and honeycombing on CT, not peripheral consolidation and ground-glass opacities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sarcoidosis</span></strong><span style=\"font-size:12.0pt\">: Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not organizing pneumonia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chronic eosinophilic pneumonia (CEP):</span></strong><span style=\"font-size:12.0pt\"> Characterized by peripheral infiltrates on imaging and an increased number of eosinophils in the lung and blood, not organizing pneumonia with granulation tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cryptogenic organizing pneumonia (COP) is identified by granulation tissue within the alveolar ducts and bronchioles, presenting with a non-productive cough, low-grade fever, and progressive dyspnea. Imaging shows bilateral patchy infiltrates and peripheral consolidation with ground-glass opacities. It is differentiated from idiopathic pulmonary fibrosis, sarcoidosis, and chronic eosinophilic pneumonia, each having unique histopathological and radiological features.</span></span></span></p>",
      "correct_choice_id": 80961,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20252,
      "choices": [
        {
          "id": 80969,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic eosinophilic pneumonia (CEP)</span></span></span></p>"
        },
        {
          "id": 80970,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute eosinophilic pneumonia</span></span></p>"
        },
        {
          "id": 80971,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypereosinophilic syndrome</span></span></p>"
        },
        {
          "id": 80972,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loeffler&#39;s syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with a history of asthma, progressive dyspnea, and weight loss over the past few months. She also reports night sweats and cough. Chest X-ray shows peripheral infiltrates, and blood tests reveal marked eosinophilia. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2491638",
      "question_audio": null,
      "question_video": null,
      "map_id": 20201,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>A) Chronic eosinophilic pneumonia (CEP)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic eosinophilic pneumonia (CEP) is characterized by the presence of peripheral infiltrates on chest imaging (often referred to <u>photographic negative of pulmonary edema</u>) and marked eosinophilia in the blood. Patients often present with a history of asthma, progressive dyspnea, weight loss, night sweats, and cough. The combination of these clinical features and imaging findings is highly suggestive of CEP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute eosinophilic pneumonia:</span></strong><span style=\"font-size:12.0pt\"> Typically presents with acute onset of respiratory failure, diffuse pulmonary infiltrates, and eosinophilia in bronchoalveolar lavage fluid but not always in blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hypereosinophilic syndrome</span></strong><span style=\"font-size:12.0pt\">: Characterized by persistent eosinophilia and multi-organ involvement, not specifically peripheral infiltrates on chest X-ray.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Loeffler&#39;s syndrome</span></strong><span style=\"font-size:12.0pt\">: Characterized by transient pulmonary infiltrates and blood eosinophilia, often due to parasitic infections, and usually resolves within a few weeks without leading to chronic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic eosinophilic pneumonia (CEP) is identified by peripheral infiltrates on chest imaging and marked eosinophilia in the blood. It presents with a history of asthma, progressive dyspnea, weight loss, night sweats, and cough. This condition is distinguished from acute eosinophilic pneumonia, hypereosinophilic syndrome, and Loeffler&#39;s syndrome based on the specific clinical features, imaging findings, and chronicity of symptoms.</span></span></span></p>",
      "correct_choice_id": 80969,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20260,
      "choices": [
        {
          "id": 81001,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-resolution computed tomography (HRCT) chest</span></span></p>"
        },
        {
          "id": 81002,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluorescence in situ hybridization (FISH)</span></span></p>"
        },
        {
          "id": 81003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bronchoalveolar lavage (BAL)</span></span></span></p>"
        },
        {
          "id": 81004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lung biopsy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents with cough, dyspnea, fatigue, weight loss, and splenomegaly. Blood tests reveal marked eosinophilia and elevated white blood cell count. Chest X-ray shows diffuse infiltrates. Bone marrow biopsy shows increased cellularity with eosinophil precursors and myeloid hyperplasia. What is the next step ?</span></span></p>",
      "unique_key": "Q1662989",
      "question_audio": null,
      "question_video": null,
      "map_id": 20208,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Fluorescence in situ hybridization (FISH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Given the clinical presentation, marked eosinophilia, and bone marrow findings, it is crucial to evaluate for specific genetic mutations associated with myeloproliferative neoplasms (MPN) variants of hypereosinophilic syndrome (HES). Fluorescence in situ hybridization (FISH) is a molecular diagnostic tool that can detect specific genetic abnormalities, such as the PDGFRA mutation, which is commonly associated with MPN-HES.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. High-resolution computed tomography (HRCT) chest:</span></strong><span style=\"font-size:12.0pt\"> While it provides detailed imaging of lung pathology, it does not identify specific genetic mutations needed for diagnosing MPN-HES.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bronchoalveolar lavage (BAL):</span></strong><span style=\"font-size:12.0pt\"> Useful for diagnosing infections and certain interstitial lung diseases but not for identifying genetic mutations associated with MPN-HES.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Lung biopsy:</span></strong><span style=\"font-size:12.0pt\"> While it can provide histopathological information, it is invasive and does not identify specific genetic mutations crucial for diagnosing MPN-HES.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For patients with marked eosinophilia and bone marrow findings suggestive of hypereosinophilic syndrome (HES), FISH testing for specific genetic mutations is essential to confirm the diagnosis and guide treatment</span></span></span></p>",
      "correct_choice_id": 81002,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20257,
      "choices": [
        {
          "id": 80989,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic<strong> </strong>eosinophilic pneumonia</span></span></p>"
        },
        {
          "id": 80990,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis</span></span></p>"
        },
        {
          "id": 80991,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropical pulmonary eosinophilia</span></span></p>"
        },
        {
          "id": 80992,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loeffler&#39;s syndrome</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents with a chronic cough, wheezing, and night sweats. Blood tests reveal marked eosinophilia. Chest X-ray shows diffuse miliary nodules. Which of the following is the most likely diagnosis ?</span></span></p>",
      "unique_key": "Q1345297",
      "question_audio": null,
      "question_video": null,
      "map_id": 20205,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Tropical pulmonary eosinophilia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tropical pulmonary eosinophilia (TPE) is characterized by chronic cough, wheezing, night sweats, and marked eosinophilia. It is caused by an immunological reaction to filarial parasites, commonly presenting with persistent infiltrates in CXR. Some patients can even have diffuse miliary mottling. This diagnosis is likely given the combination of eosinophilia, respiratory symptoms, and characteristic radiographic findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chronic eosinophilic pneumonia:</span></strong><span style=\"font-size:12.0pt\"> Typically presents with peripheral infiltrates on chest imaging, not miliary nodules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tuberculosis</span></strong><span style=\"font-size:12.0pt\">: Miliary tuberculosis can present with diffuse miliary nodules, but it is not typically associated with marked eosinophilia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Loeffler&#39;s syndrome:</span></strong><span style=\"font-size:12.0pt\"> Characterized by transient pulmonary infiltrates and blood eosinophilia, often due to parasitic infections, but typically resolves within a few weeks and does not present with chronic symptoms or miliary nodules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tropical pulmonary eosinophilia (TPE) is characterized by chronic cough, wheezing, night sweats, and marked eosinophilia. It is caused by an immunological reaction to filarial parasites and commonly presents with persistent infiltrates and diffuse miliary nodules on chest X-ray. This condition is distinguished from chronic eosinophilic pneumonia, tuberculosis, and Loeffler&#39;s syndrome based on the combination of eosinophilia, respiratory symptoms, and characteristic radiographic findings.</span></span></span></p>",
      "correct_choice_id": 80991,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20272,
      "choices": [
        {
          "id": 81049,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphangioleiomyomatosis (LAM)</span></span></p>"
        },
        {
          "id": 81050,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary Langerhans cell histiocytosis (PLCH)</span></span></span></p>"
        },
        {
          "id": 81051,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Idiopathic pulmonary fibrosis (IPF)</span></span></span></p>"
        },
        {
          "id": 81052,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male smoker presents with chronic cough and dyspnea. He reports unintentional weight loss and episodes of spontaneous pneumothorax. High-resolution CT of the chest shows numerous thin-walled cysts and nodules predominantly in the upper lobes. Lung biopsy reveals characteristic tennis racquet like granules on electron microscopy. What is the likely diagnosis?</span></span></p>",
      "unique_key": "Q8834561",
      "question_audio": null,
      "question_video": null,
      "map_id": 20227,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Pulmonary Langerhans cell histiocytosis (PLCH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary Langerhans cell histiocytosis (PLCH) is a smoking-related interstitial lung disease characterized by the presence of Langerhans cells. Patients typically present with chronic cough, dyspnea, spontaneous pneumothorax, and weight loss. High-resolution CT shows numerous thin-walled cysts and nodules predominantly in the upper lobes. Lung biopsy revealing Birbeck granules on electron microscopy confirms the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Lymphangioleiomyomatosis (LAM):</span></strong><span style=\"font-size:12.0pt\"> Typically affects women of childbearing age and is characterized by diffuse thin-walled cysts but not associated with Birbeck granules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Idiopathic pulmonary fibrosis (IPF</span></strong><span style=\"font-size:12.0pt\">): Presents with progressive fibrosis and honeycombing on imaging, not thin-walled cysts and nodules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sarcoidosis:</span></strong><span style=\"font-size:12.0pt\"> Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not thin-walled cysts and Birbeck granules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary Langerhans cell histiocytosis (PLCH) is a smoking-related interstitial lung disease characterized by numerous thin-walled cysts and nodules predominantly in the upper lobes and presence of Birbeck granules on electron microscopy.</span></span></span></p>",
      "correct_choice_id": 81050,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20263,
      "choices": [
        {
          "id": 81013,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measurement of serum precipitating antibodies</span></span></p>"
        },
        {
          "id": 81014,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Laboratory testing for connective tissue disease</span></span></span></p>"
        },
        {
          "id": 81015,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transbronchial biopsy</span></span></p>"
        },
        {
          "id": 81016,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical lung biopsy</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old non-smoker male with progressive dry cough, SOB, and NYHA Class III presents with fine bibasilar crackles and no clubbing. HRCT is shown. Which investigation is required for further evaluation?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-133026.png\" style=\"height:296px; width:300px\" /></span></span></p>",
      "unique_key": "Q3633700",
      "question_audio": null,
      "question_video": null,
      "map_id": 20211,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Laboratory testing for connective tissue disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HRCT shows Bibasilar symmetric ground glass opacities with reticulation and traction bronchiectasis which is highly suggestive of Non Specific Interstitial Pneumonia (NSIP). Presence of NSIP suggests the possibility of an underlying connective tissue disease (CTD). Laboratory testing for connective tissue diseases can help identify any underlying autoimmune conditions that may be contributing to the patient&#39;s lung pathology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Measurement of serum precipitating antibodies:</span></strong><span style=\"font-size:12.0pt\"> Typically used to diagnose hypersensitivity pneumonitis, which is less likely given the lack of exposure history.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Transbronchial biopsy:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Can be helpful in certain interstitial lung diseases but may not provide sufficient tissue for a definitive diagnosis of NSIP or an underlying CTD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Surgical lung biopsy</span></strong><span style=\"font-size:12.0pt\">: Provides more tissue for diagnosis but is more invasive. It may be considered if initial non-invasive tests do not yield a diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Laboratory testing for connective tissue diseases is essential when HRCT shows features suggestive of Non Specific Interstitial Pneumonia (NSIP) to identify any underlying autoimmune conditions.</span></span></span></p>",
      "correct_choice_id": 81014,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20266,
      "choices": [
        {
          "id": 81025,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pirfenidone&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>"
        },
        {
          "id": 81026,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bosentan</span></span></p>"
        },
        {
          "id": 81027,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcysteine</span></span></p>"
        },
        {
          "id": 81028,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prednisolone/azathioprine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old female is referred for chronic cough and dyspnea with exertion. Over the past year, her symptoms have steadily worsened. Pulmonary function testing shows FVC: 72%, FEV1: 80%, DLCO: 38%. HRCT of the chest is shown. Lung biopsy shows foci of scarring dispersed and surrounded by healthy lung parenchyma and fibroblasts. Which of the following is the appropriate therapy for this patient?<strong>&nbsp; </strong></span></span></span></p>",
      "unique_key": "Q6669731",
      "question_audio": null,
      "question_video": null,
      "map_id": 20214,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Pirfenidone</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">HRCT shows bibasilar reticular markings with traction bronchiectasis and honeycombing which is suggestive of Usual Interstitial Pneumonia (UIP). The</span><span style=\"font-size:12.0pt\"> patient&rsquo;s clinical presentation, pulmonary function test results, CT findings, and lung biopsy are consistent with the diagnosis of idiopathic pulmonary fibrosis (IPF). Pirfenidone is an antifibrotic agent specifically approved for the treatment of IPF, as it helps to slow disease progression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Bosentan:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Primarily used to treat pulmonary arterial hypertension, not idiopathic pulmonary fibrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Acetylcysteine</span></strong><span style=\"font-size:12.0pt\">: An antioxidant used in the management of various conditions, but not first-line for IPF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Prednisolone/azathioprine:</span></strong><span style=\"font-size:12.0pt\"> Immunosuppressive therapy that has not shown benefit and may even be harmful in patients with IPF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pirfenidone is the appropriate therapy for idiopathic pulmonary fibrosis (IPF), as it helps to slow disease progression.</span></span></span></p>",
      "correct_choice_id": 81025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20245,
      "choices": [
        {
          "id": 80941,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE is elevated in 60% of cases</span></span></span></p>"
        },
        {
          "id": 80942,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypercalcemia occurs in about 10% of patients</span></span></span></p>"
        },
        {
          "id": 80943,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BAL CD4/CD8 ratio &gt; 3.5 is a characteristic finding</span></span></span></p>"
        },
        {
          "id": 80944,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lung biopsy is the gold standard for diagnosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with suspected sarcoidosis presents with bilateral hilar lymphadenopathy, erythema nodosum, and distal renal tubular acidosis (dRTA). Which of the following statements about the disease is false?</span></span></p>",
      "unique_key": "Q4983349",
      "question_audio": null,
      "question_video": null,
      "map_id": 20193,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>D) Lung biopsy is the gold standard for diagnosis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While lung biopsy showing non-caseating granulomas is highly suggestive of sarcoidosis and can be a critical component in diagnosing the disease, it is not considered the definitive gold standard as the diagnosis often relies on a combination of clinical, radiographic, and histopathological findings. Other conditions, such as berylliosis and tuberculosis, can also present with non-caseating granulomas, so clinical correlation and exclusion of other diseases are essential for an accurate diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. ACE is elevated in 60% of cases</span></strong><span style=\"font-size:12.0pt\">: Elevated angiotensin-converting enzyme (ACE) levels are seen in about 60% of patients with sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypercalcemia occurs in about 10% of patients</span></strong><span style=\"font-size:12.0pt\">: Hypercalcemia occurs in approximately 10% of patients with sarcoidosis due to increased production of vitamin D by granulomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. BAL CD4/CD8 ratio &gt; 3.5 is a characteristic finding</span></strong><span style=\"font-size:12.0pt\">: A high CD4/CD8 ratio in bronchoalveolar lavage (BAL) fluid is a characteristic finding in sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While lung biopsy showing non-caseating granulomas is highly suggestive of sarcoidosis and can be critical in diagnosis, it is not considered the gold standard as the diagnosis often relies on a combination of clinical, radiographic, and histopathological findings. Other conditions can also present with non-caseating granulomas, necessitating clinical correlation and exclusion of other diseases for accurate diagnosis.</span></span></span></p>",
      "correct_choice_id": 80944,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20196,
      "choices": [
        {
          "id": 80746,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></span></p>"
        },
        {
          "id": 80747,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate</span></span></p>"
        },
        {
          "id": 80748,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bleomycin</span></span></p>"
        },
        {
          "id": 80749,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cisplatin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 70-year-old male with a history of atrial fibrillation presents with progressive dyspnea and a dry cough over the past three months. He has been on amiodarone therapy for the past year. High-resolution CT of the chest reveals findings consistent with interstitial lung disease (ILD). All of the following medications are known to cause ILD except:</span></span></span></p>",
      "unique_key": "Q1346440",
      "question_audio": null,
      "question_video": null,
      "map_id": 20144,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12pt\"><strong> D)</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Cisplatin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amiodarone, methotrexate, and bleomycin are well-documented causes of drug-induced interstitial lung disease (ILD). Amiodarone is an antiarrhythmic medication often associated with pulmonary toxicity, methotrexate is used for autoimmune diseases and certain cancers, and bleomycin is a chemotherapeutic agent known for its pulmonary toxicity. Cisplatin, another chemotherapeutic agent, is not typically associated with ILD; its primary toxicities are nephrotoxicity and ototoxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">A. Amiodarone:</span></strong><span style=\"font-size:12.0pt\"> Known to cause ILD, particularly with long-term use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">B. Methotrexate:</span></strong><span style=\"font-size:12.0pt\"> Associated with ILD in patients, particularly those with rheumatoid arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">C. Bleomycin:</span></strong><span style=\"font-size:12.0pt\"> A chemotherapeutic agent well known for its potential to cause ILD</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Educational Objective</u>: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amiodarone, methotrexate, and bleomycin are known to cause drug-induced interstitial lung disease (ILD), while cisplatin is not typically associated with ILD; its primary toxicities are nephrotoxicity and ototoxicity.</span></span></span></p>",
      "correct_choice_id": 80749,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20205,
      "choices": [
        {
          "id": 80781,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory bronchiolitis associated ILD</span></span></p>"
        },
        {
          "id": 80782,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Desquamative Interstitial Pneumonia</span></span></p>"
        },
        {
          "id": 80783,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Langerhans Cell Histiocytosis</span></span></span></p>"
        },
        {
          "id": 80784,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usual Interstitial Pneumonia</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male with a 30-pack-year smoking history presents with progressive dyspnea and chronic cough. High-resolution CT of the chest shows diffuse interstitial changes. Which of the following interstitial lung diseases is least likely to be associated with smoking?</span></span></p>",
      "unique_key": "Q2706473",
      "question_audio": null,
      "question_video": null,
      "map_id": 20153,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;Ans. D)&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Usual Interstitial Pneumonia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Usual Interstitial Pneumonia (UIP) is the histopathological pattern seen in idiopathic pulmonary fibrosis, which is not specifically associated with smoking. In contrast, respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia, and Langerhans cell histiocytosis are all strongly associated with smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Respiratory bronchiolitis associated ILD:</span></strong><span style=\"font-size:12.0pt\"> Commonly seen in smokers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Desquamative Interstitial Pneumonia:</span></strong><span style=\"font-size:12.0pt\"> Strongly associated with smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Langerhans Cell Histiocytosis:</span></strong><span style=\"font-size:12.0pt\"> Typically seen in smokers and characterized by cystic lung disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Educational objective</u>:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Usual Interstitial Pneumonia <strong>is least likely to be associated with smoking.</strong></span></span></span></p>",
      "correct_choice_id": 80784,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20207,
      "choices": [
        {
          "id": 80789,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute silicosis</span></span></p>"
        },
        {
          "id": 80790,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary alveolar proteinosis (PAP)</span></span></p>"
        },
        {
          "id": 80791,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic pulmonary fibrosis (IPF)</span></span></p>"
        },
        {
          "id": 80792,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypersensitivity pneumonitis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of working in a construction agency involved in rock tunnelling presents with acute onset of dyspnea, cough, and fatigue for the last 3 weeks. High-resolution CT shows diffuse ground-glass opacities and a crazy paving pattern. Bronchoalveolar lavage reveals large amounts of periodic acid-Schiff-positive material. Which of the following conditions is most likely ?</span></span></p>",
      "unique_key": "Q7012063",
      "question_audio": null,
      "question_video": null,
      "map_id": 20154,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Acute silicosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute silicosis can present with features similar to pulmonary alveolar proteinosis (PAP), including diffuse ground-glass opacities and a crazy paving pattern on high-resolution CT. The exposure to silica dust leads to the accumulation of surfactant-like material in the alveoli, which can be identified as periodic acid-Schiff-positive material on bronchoalveolar lavage. Whole lung lavage can provide symptomatic relief but the disease is progressive despite treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Pulmonary alveolar proteinosis (PAP):</span></strong><span style=\"font-size:12.0pt\"> Although PAP can present with similar imaging findings, the patient&#39;s occupational history and acute onset suggest acute silicosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Idiopathic pulmonary fibrosis (IPF):</span></strong><span style=\"font-size:12.0pt\"> Typically presents with chronic progressive dyspnea and honeycombing on imaging, not acute symptoms and crazy paving pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Hypersensitivity pneumonitis:</span></strong><span style=\"font-size:12.0pt\"> Related to environmental exposures, presenting with cough, dyspnea, and fatigue, but typically involves centrilobular nodules rather than crazy paving pattern</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Educational Objective</u>:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute silicosis can present with diffuse ground-glass opacities and a crazy paving pattern on high-resolution CT, and bronchoalveolar lavage may reveal large amounts of periodic acid-Schiff-positive material, reflecting occupational exposure to silica dust.</span></span></span></p>",
      "correct_choice_id": 80789,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20208,
      "choices": [
        {
          "id": 80793,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interstitial lung disease (ILD)</span></span></span></p>"
        },
        {
          "id": 80794,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic obstructive pulmonary disease (COPD)</span></span></p>"
        },
        {
          "id": 80795,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid arthritis</span></span></p>"
        },
        {
          "id": 80796,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphoma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man with a long history of working in construction presents with chronic cough and shortness of breath. He reports joint pain and stiffness, and a recent chest X-ray shows interstitial lung disease (ILD). Which of the following conditions is least likely to be associated with his diagnosis of silicosis?</span></span></p>",
      "unique_key": "Q9128133",
      "question_audio": null,
      "question_video": null,
      "map_id": 20156,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Lymphoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Silicosis is primarily associated with pulmonary conditions such as interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) due to the inhalation of silica dust. It can also be associated with autoimmune conditions like rheumatoid arthritis, known as Caplan&#39;s syndrome. However, there is no direct association between silicosis and the development of lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Interstitial lung disease (ILD):</span></strong><span style=\"font-size:12.0pt\"> Silicosis is a form of ILD caused by inhalation of silica dust.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chronic obstructive pulmonary disease (COPD):</span></strong><span style=\"font-size:12.0pt\"> Long-term exposure to silica can lead to COPD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Rheumatoid arthritis:</span></strong><span style=\"font-size:12.0pt\"> Silicosis can be associated with rheumatoid arthritis in the form of Caplan&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Silicosis is primarily associated with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) due to inhalation of silica dust and can also be associated with autoimmune conditions like rheumatoid arthritis, but not with lymphoma.</span></span></span></p>",
      "correct_choice_id": 80796,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20210,
      "choices": [
        {
          "id": 80801,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesotheliomas are strongly associated with smoking</span></span></p>"
        },
        {
          "id": 80802,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Short-term asbestos exposures of &le;1&ndash;2 years can lead to mesotheliomas</span></span></p>"
        },
        {
          "id": 80803,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesotheliomas are not associated with asbestos exposure</span></span></p>"
        },
        {
          "id": 80804,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesotheliomas develop within a few years of exposure to asbestos</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with a history of working in shipyards presents with chest pain and shortness of breath. Imaging reveals a pleural mass, and biopsy confirms malignant mesothelioma. Which of the following is true regarding the association of mesotheliomas with asbestos exposure?</span></span></p>",
      "unique_key": "Q4768282",
      "question_audio": null,
      "question_video": null,
      "map_id": 20159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;Ans. B) Short-term asbestos exposures of &le;1&ndash;2 years can lead to mesotheliomas</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mesotheliomas, both pleural and peritoneal, are strongly associated with asbestos exposure. Unlike lung cancers, they are not associated with smoking. Even relatively short-term asbestos exposures of &le;1&ndash;2 years, occurring up to 40 years in the past, can lead to the development of mesotheliomas. This underscores the importance of obtaining a thorough environmental exposure history in patients with suspected mesothelioma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Mesotheliomas are strongly associated with smoking:</span></strong><span style=\"font-size:12.0pt\"> Mesotheliomas are not associated with smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mesotheliomas are not associated with asbestos exposure:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Mesotheliomas are indeed associated with asbestos exposure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Mesotheliomas develop within a few years of exposure to asbestos:</span></strong><span style=\"font-size:12.0pt\"> Mesotheliomas can develop decades after exposure to asbestos.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mesotheliomas are strongly associated with asbestos exposure and can develop even after short-term exposures of &le;1&ndash;2 years, occurring up to 40 years in the past. They are not associated with smoking.</span></span></span></p>",
      "correct_choice_id": 80802,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20212,
      "choices": [
        {
          "id": 80809,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Significant pulmonary impairment</span></span></p>"
        },
        {
          "id": 80810,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Past exposure to asbestos</span></span></p>"
        },
        {
          "id": 80811,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pleural effusion</span></span></p>"
        },
        {
          "id": 80812,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Active tuberculosis infection</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old retired construction worker presents for a routine check-up. His chest radiograph is shown. What does it indicate?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-124125.png\" style=\"height:285px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5853742",
      "question_audio": null,
      "question_video": null,
      "map_id": 20160,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Past exposure to asbestos</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CXR shows bilateral calcified pleural plaques consistent with asbestos-related pleural disease (usually seen along the parietal pleura, particularly in the lower lung fields, diaphragm, and cardiac border). This indicates past exposure to asbestos. Pleural plaques imply exposure to asbestos but do not indicate pulmonary impairment by themselves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation</u></strong><strong>: </strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Significant pulmonary impairment:</span></strong><span style=\"font-size:12.0pt\"> Pleural plaques indicate exposure but do not imply pulmonary impairment without additional manifestations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pleural effusion</span></strong><span style=\"font-size:12.0pt\">: Benign pleural effusions can occur with asbestos exposure but are not seen in this CXR</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Active tuberculosis infection:</span></strong><span style=\"font-size:12.0pt\"> Pleural plaques are not associated with tuberculosis (but silicosis has association)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong> </span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chest X-ray showing bilateral calcified pleural plaques indicates past exposure to asbestos. Pleural plaques are a hallmark of asbestos exposure but do not imply significant pulmonary impairment without additional findings.</span></span></span></p>",
      "correct_choice_id": 80810,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20270,
      "choices": [
        {
          "id": 81041,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute interstitial pneumonia (AIP)</span></span></p>"
        },
        {
          "id": 81042,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory distress syndrome (ARDS)</span></span></p>"
        },
        {
          "id": 81043,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryptogenic organizing pneumonia (COP)</span></span></p>"
        },
        {
          "id": 81044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Idiopathic pulmonary fibrosis (IPF)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman presents with acute onset of severe dyspnea and fever. She was previously healthy but has rapidly deteriorated over the past week. Chest X-ray shows diffuse bilateral alveolar infiltrates, and HRCT of the chest reveals widespread ground-glass opacities and consolidation. Routine work up did not reveal any identifiable cause. Lung biopsy demonstrates diffuse alveolar damage with hyaline membrane formation. What is the likely diagnosis ?</span></span></p>",
      "unique_key": "Q2021493",
      "question_audio": null,
      "question_video": null,
      "map_id": 20217,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Acute interstitial pneumonia (AIP)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial pneumonia (AIP), also known as Hamman-Rich syndrome, is characterized by the rapid onset of severe respiratory symptoms, including dyspnea and fever, in a previously healthy individual. The imaging findings of diffuse bilateral alveolar infiltrates, widespread ground-glass opacities, and consolidation, along with lung biopsy showing diffuse alveolar damage and hyaline membrane formation, are classic for AIP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute respiratory distress syndrome (ARDS):</span></strong><span style=\"font-size:12.0pt\"> While ARDS also presents with diffuse alveolar damage and similar imaging findings, it is typically secondary to an identifiable cause such as sepsis, trauma, or pneumonia, whereas AIP occurs without a known trigger.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cryptogenic organizing pneumonia (COP)</span></strong><span style=\"font-size:12.0pt\">: Usually presents with subacute symptoms and patchy lung infiltrates, not rapid onset and diffuse alveolar damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Idiopathic pulmonary fibrosis (IPF):&nbsp;</span></strong><span style=\"font-size:12.0pt\">Characterized by chronic progressive dyspnea and fibrosis with honeycombing, not acute onset or diffuse alveolar damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial pneumonia (AIP) is characterized by rapid onset of severe respiratory symptoms, diffuse bilateral alveolar infiltrates, and lung biopsy showing diffuse alveolar damage with hyaline membrane formation.</span></span></span></p>",
      "correct_choice_id": 81041,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}